Alimera Sciences to Present at the 13th Annual LD Micro Main Event Virtual Conference
Alimera Sciences (Nasdaq: ALIM) will present a corporate overview at the LD Micro Main Event virtual investor conference on December 14 at 8:20 AM PST/11:20 AM EST. CEO Rick Eiswirth's presentation will include a 10-minute overview followed by a Q&A session. Interested participants can register to attend the presentation at ve.mysequire.com. Alimera focuses on the commercialization and development of prescription ophthalmic treatments for retinal diseases, addressing significant unmet needs in this therapeutic area.
- None.
- None.
ATLANTA, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, today announces that CEO Rick Eiswirth will present a corporate overview at the 13th Annual LD Micro Main Event virtual investor conference on Monday, December 14 at 8:20 AM PST/11:20 AM EST. The format will be a 10-minute presentation followed by a 10-minute Q&A session with a panel of investors and analysts.
Interested participants can register to view the presentation and Q&A session at ve.mysequire.com/
View Alimera Sciences’ LD Micro profile here.
About Alimera Sciences, Inc.
Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people in our aging populations. For more information, please visit www.alimerasciences.com.
About LD Micro/SEQUIRE
LD Micro began in 2006 with the sole purpose of being an independent resource to the microcap world. What started as a newsletter highlighting unique companies, transformed into a prominent event platform in the space. For more information, please visit ldmicro.com.
| For press inquiries: Jules Abraham for Alimera Sciences 917-885-7378 julesa@coreir.com | For investor inquiries: Scott Gordon for Alimera Sciences scottg@coreir.com |
FAQ
When will Alimera Sciences present at the LD Micro Main Event?
Who will be presenting for Alimera Sciences at the investor conference?
How long is Alimera's presentation at the LD Micro Conference?
Where can I register to view Alimera Sciences' presentation?
What does Alimera Sciences focus on?
